FERMT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.344800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.812200E-01
Normal-vs-Stage2
5.692600E-01
Normal-vs-Stage3
3.624400E-01
Normal-vs-Stage4
8.322400E-01
Stage1-vs-Stage2
7.613400E-01
Stage1-vs-Stage3
9.111200E-01
Stage1-vs-Stage4
2.890600E-01
Stage2-vs-Stage3
7.362400E-01
Stage2-vs-Stage4
3.203400E-01
Stage3-vs-Stage4
3.234800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.109400E-01
Normal-vs-AfricanAmerican
8.119000E-01
Normal-vs-Asian
3.985000E-01
Caucasian-vs-AfricanAmerican
6.180200E-01
Caucasian-vs-Asian
4.047200E-01
AfricanAmerican-vs-Asian
4.278400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.096000E-01
Normal-vs-Female
5.918000E-01
Male-vs-Female
4.079200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.414600E-01
Normal-vs-Age(41-60Yrs)
8.026800E-01
Normal-vs-Age(61-80Yrs)
4.902200E-01
Normal-vs-Age(81-100Yrs)
1.046230E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.397400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.104600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.487200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.843900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.835700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.473030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.960240E-01
Normal-vs-Daily Drinker
6.249800E-02
Normal-vs-Weekly Drinker
7.954400E-01
Normal-vs-Occasional Drinker
3.642400E-01
Normal-vs-Social Drinker
8.762400E-01
Non Drinker-vs-Daily Drinker
6.057800E-01
Non Drinker-vs-Weekly Drinker
1.176610E-01
Non Drinker-vs-Occasional Drinker
5.610200E-01
Non Drinker-vs-Social Drinker
9.391700E-02
Daily Drinker-vs-Weekly Drinker
8.580100E-02
Daily Drinker-vs-Occasional Drinker
2.861400E-01
Daily Drinker-vs-Social Drinker
5.838200E-02
Weekly Drinker-vs-Occasional Drinker
3.552800E-01
Weekly Drinker-vs-Social Drinker
5.287200E-01
Occasional Drinker-vs-Social Drinker
1.804000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.763200E-01
Normal-vs-Grade 2
6.172600E-01
Normal-vs-Grade 3
7.912800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.085600E-01
Grade 1-vs-Grade 3
8.279400E-01
Grade 1-vs-Grade 4
8.763200E-01
Grade 2-vs-Grade 3
3.415400E-01
Grade 2-vs-Grade 4
6.172600E-01
Grade 3-vs-Grade 4
7.912800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.070200E-01
Normal-vs-NonDiabetic
3.865800E-01
Diabetic-vs-NonDiabetic
4.199400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.306200E-01
Normal-vs-NoPancreatitis
4.838000E-01
Pancreatitis-vs-NoPancreatitis
9.993200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.499000E-01
Normal-vs-N1
5.688600E-01
N0-vs-N1
4.151800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.038600E-01
Normal-vs-TP53-NonMutant
3.437200E-01
TP53-Mutant-vs-TP53-NonMutant
3.412000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
